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Introduction
Protein synthesis in secretory cells is exquisitely regulated to 
meet the changing demands for secreted proteins that participate 
in physiological and developmental processes. One example of 
developmentally regulated cells with extraordinary secretory   
capacity are the chondrocytes of the developing skeleton, which 
differentiate from a simple mesenchymal condensation to a 
highly ECM-enriched group of cells within 24 h. Effectors of 
protein  folding  and  transport  are  necessarily  up-regulated  to 
cope with the increased protein load and support the transition to 
a highly secretory phenotype. Concomitantly, the synthesis and 
secretion of collagens and other ECM proteins that comprise the 
cartilage matrix are also dynamically regulated as the skeleton 
grows and develops.
The collagens are a large family of structural proteins that 
form  diverse  supramolecular  assemblies  within  the  ECM 
throughout the body and skeleton. These proteins are defined by 
a repeating Gly-X-Y motif in the pro– chains, which associate 
in the ER into a triple helix (Lamandé and Bateman, 1999). The 
general process of synthesis, assembly, and formation of the   
helical domain is similar for all collagens. Collagen precursors 
are co-translated into the ER, where secondary modifications 
occur that are essential for oligomerization and stabilization   
by the ER-resident collagen chaperone Hsp47. Trimers are   
exported from the ER and trafficked through the Golgi network, 
where they are further modified by N-linked oligosaccharide 
addition before secretion into the extracellular space and orga-
nization into higher order structures.
The mean fibrillar collagen, when formed into a trimer, 
adopts a rigid, rodlike structure of >300 nm in length. This is 
too large to fit into typical 60–80-nm ER–Golgi transport vesi-
cles enshrouded by the COPII coat protein, sparking a contro-
versy as to whether a new vesicular transport model needs to be 
invoked (Fromme and Schekman, 2005). Procollagens are segre-
gated at ER exit sites into large transport complexes that are 
distinct from typical smaller ER vesicles labeled by ERGIC-53 
and VSVG (vesicular stomatitis virus G) protein (Stephens   
and Pepperkok, 2002). More specifically, in chondrocytes, the 
M
elanoma inhibitory activity member 3 (MIA3/
TANGO1) is an evolutionarily conserved en-
doplasmic reticulum resident transmembrane 
protein. Recent in vitro studies have shown that it is re-
quired for the loading of collagen VII, but not collagen I, 
into COPII-coated transport vesicles. In this paper, we 
show that mice lacking Mia3 are defective for the secre-
tion of numerous collagens, including collagens I, II, III, IV, 
VII,  and  IX,  from  chondrocytes,  fibroblasts,  endothelial 
cells, and mural cells. Collagen deposition by these cell 
types is abnormal, and extracellular matrix composition is 
compromised. These changes are associated with intra-
cellular accumulation of collagen and the induction of a 
strong unfolded protein response, primarily within the de-
veloping skeleton. Chondrocyte maturation and bone 
mineralization  are  severely  compromised  in  Mia3-null 
embryos, leading to dwarfism and neonatal lethality. 
Thus, Mia3’s role in protein secretion is much broader 
than previously realized, and it may, in fact, be required 
for the efficient secretion of all collagen molecules in 
higher organisms.
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coronary artery disease and early onset myocardial infarct (MI;   
Samani et al., 2007; Kathiresan et al., 2009). Down-regulation 
of  MIA3  has  been  observed  in  malignant  melanoma  (Arndt 
and Bosserhoff, 2006) as well as colon and hepatocellular car-
cinomas (Arndt and Bosserhoff, 2007), but it remains unclear 
whether these changes are epiphenomena, are causative, or 
are correlates of cancerous progression without an active role.   
Despite this intriguing set of observations, it has not been pos-
sible to tie these disparate results together into a clear picture of 
the function of Mia3.
To clarify its function, we generated a null allele of Mia3 
in the mouse. Mia3 knockouts display a chondrodysplasia that 
causes dwarfing of the fetus, peripheral edema, and perinatal   
lethality. Further analysis reveals a substantial shift in collagen 
metabolism, likely resulting from delayed transit through the 
secretory pathway. This phenotype combines aspects of several 
different diseases caused by defects in collagen production. Our 
analysis highlights the sensitivity of the chondrogenic/skeleto-
genic processes to defects in protein secretion and further sug-
gests that regulators of ER and Golgi function may be causative 
in cases of recessive chondrodysplasias that remain as yet un-
mapped. The generalized role of Mia3 in escorting all collagens 
examined to date, including collagens I, II, III, IV, VII, and IX, 
but not other ECM components, such as fibronectin or aggre-
can, indicates that this protein plays a unique role within the cell 
to facilitate the nucleation of large ER transport vesicles dedi-
cated to the export of collagens and perhaps collagen-associated 
molecules of the ECM.
distribution of aggrecan, another large secreted ECM glycopro-
tein, has a localization distinct from that of Col2a1 (collagen II) 
in the ER (Vertel et al., 1989), which strongly suggests that col-
lagens are actively packaged by specific cargo receptors and/or 
chaperones within a unique compartment.
A genome-wide RNAi screen using insect cells to identify 
transport components and other factors required for Golgi   
organization (TANGO [transport and Golgi organization] genes) 
led to the identification of the Drosophila melanogaster homo-
logue of the vertebrate gene MIA3, also known as TANGO1 
(Bard et al., 2006). MIA3 is a unique 1,907 amino acid pro-
tein, which has recently been proposed to act as an ER-resident 
chaperone for Col7a1 (collagen VII; Saito et al., 2009b) based 
on elegant biochemical and cell biological analyses. Saito   
et al. (2009b) found that Mia3 spans the ER membrane and binds 
Col7a1 via an SH3 (Src homology 3)-like fold residing within   
the ER lumen, whereas on the cytoplasmic face, a C-terminal 
proline-rich domain binds the Sec23 and Sec24 proteins of the 
COPII coat complex. This dual interaction is hypothesized to 
facilitate the generation and packaging of ER megavesicles of 
sufficient size to support the transport of the bulky Col7a1 tri-
mer. Intriguingly, they also found that knockdown of MIA3 
failed to affect the secretion of Col1 (collagen I), suggesting 
that MIA3 was required for efficient packaging of only a subset 
of collagens.
Providing another clue toward the function of Mia3, 
unbiased genetic analyses of heart disease in human patients 
have linked a single-nucleotide polymorphism in MIA3 with 
Figure 1.  Mia3 is an ER-associated protein. (A) Hydropathy chart, exon alignment, and proposed domain structure of Mia3 with two antibody (-Mia3) 
epitopes indicated. SP, signal peptide; SH3, putative SH3-like fold; TM, transmembrane domain; PRD, proline-rich domain; pred. MM, predicted molecular 
mass. (B and C) Mia3 intron/exon map and description of the targeted allele. Nucleotides highlighted in red correspond to exon2 and exon3 sequences. 
LacZ/neo, LacZ/neomycin. (D) -Mia3 SH3 polyclonal antibodies show punctate intracellular staining that is absent in Mia3-null MEFs or nonpermeabi-
lized cells. (E) Western blot analysis of total protein, membrane (membr), and cytosolic (cyto) fractions from wt and Mia3
/ 14.5-dpc embryos reveals 
two major bands near 250 kD with several smaller isoforms or degradation products in the membrane fraction. NS, nonspecific antibody cross-reactivity; 
C-term, C terminus; KO, knockout. Molecular masses are given in kilodaltons. (F) Immunofluorescent colocalization analyses of -Mia3 SH3 with antibodies 
against calnexin, Hsp47 (SerpinH1), ERGIC-53 (Lman1), and GM130 in primary chondrocytes reveals an Mia3 protein within punctate structures on the 
ER membrane. Insets detail regions boxed in red. Bars, 10 µm.937 Collagen disruption in Mia3
/ mice • Wilson et al.
To further delineate the subcellular localization of Mia3, 
cytosolic and membrane fractions of wt and mutant embryos 
were compared using SDS-PAGE and Western blotting (Fig. 1 E).   
Mia3 contains eight putative N-linked glycosylation sites, and 
multiple high molecular mass bands (>150 kD) were observed 
with  both  antibodies,  which  is  consistent  with  the  presence 
of  multiple  isoforms  and/or  posttranslational  modifications 
of Mia3. These bands are missing from the mutant embryos, 
verifying that we have eliminated expression of the large SH3 
domain–containing isoform of Mia3. Two bands migrating at 
80–90 kD are seen with the C-terminal antibody in both wt 
and mutant cells. These are close to the expected size of the 
truncated Mia3 isoform (molecular mass of 86.9 kD) predicted 
by an alternate promoter upstream of exon1B (Fig. 1 C). Mass 
spectrometry  of  immunoprecipitates  from  embryonic  tissue   
using the C-terminal antibody confirms the absence of the larger 
SH3 domain–containing isoform in mutant lysates and the pres-
ence of the smaller SH3 domainless isoform in both mutant and 
wt animals (Fig. S1 E).
Immunofluorescent detection of Mia3 in primary chon-
drocytes and MEFs using the polyclonal anti-SH3 antibody   
reveals that Mia3 is present in regions demarcated by the ER-
resident proteins calnexin and HSP47 (Fig. 1 F). ERGIC-53 do-
mains are adjacent but mostly nonoverlapping with Mia3, and 
Mia3 is very weakly detected in the region delineated by the 
cis-Golgi marker GM130. These results are consistent with the 
observations of Saito et al. (2009b), and we conclude that Mia3 
resides primarily on the ER membrane and does not transit 
through the Golgi apparatus.
Mice carrying a single targeted allele (Mia3
+/) are fertile 
and show no gross evidence of haploinsufficiency. Homozy-
gous mice, although recovered in the expected Mendelian fre-
quencies, exhibit short-limbed dwarfism and die at birth (100% 
  penetrant; Table I). Neonates fail to breathe and are often edemic 
with subdermal microhemorrhages. Skin and other tissues 
were noted to be particularly fragile during dissection. Mia3
/  
embryos first appear morphologically distinct at 15.5–16.5   
dpc (Fig. 2, A and B) with shortening of the snout and limbs,   
a subtle reduction in stature, and apparent tightening of the   
normally wrinkled dermis. These hallmarks of the mutant 
phenotype are preserved at 18.5 dpc, and the body axis is fur-
ther shortened by 50% respective to controls (Fig. 2, C and D). 
Results
To elucidate the role of MIA3 in vivo, we characterized the   
phenotype of a Mia3 knockout mouse. Mia3 contains a putative 
signal peptide, an N-terminal SH3 domain followed by two 
coiled-coil domains, a transmembrane domain, and a C-terminal 
proline-rich domain (Fig. 1 A). A gene-targeting cassette encod-
ing a LacZ/neomycin fusion protein was inserted in frame   
11 bases into the beginning of the second exon, replacing the 
contents of this exon and all of exon3 (Fig. 1, B and C). This 
vector deletes the SH3 domain that has been shown to mediate 
interactions with Col7a1 (Saito et al., 2009b). Correct targeting 
events were confirmed by Southern blot analysis using both 5 
and 3 genomic probes as well as PCR (Fig. S1 A).
Cross-species  alignments  suggest  the  existence  of  an 
alternate promoter and coding exon within the sixth intron, 
which we refer to as exon1B (Fig. 1, A and B). cDNAs initiat-
ing in this exon are present in both mouse and human genomes 
(University of California Santa Cruz Genome Browser), and 
numerous ESTs joining exons 1B and 7 confirm that this is a 
valid transcript. We further verified this by cloning exon 1B–7 
fusion transcripts by RT-PCR from both wild-type (wt) and 
knockout embryos (Fig. S1 B). Translation of this hypothetical 
protein initiates in frame immediately before the transmem-
brane domain of full-length Mia3 but lacks a well-defined sig-
nal peptide (SignalP 3.0; ExPASy proteomics server). Given 
that the COPII-binding proline-rich domain is present in this 
isoform, it is possible that it has a cytoplasmic role that is dis-
tinct from the proposed ER cargo-binding role of full-length 
Mia3. To address this issue, affinity-purified rabbit polyclonal 
antibodies were raised against the purified SH3 domain as 
well as a linear peptide within the C-terminal tail. Immuno-
histochemical staining of 14.5–d postcoitum (dpc) embryonic 
limbs  with  the  anti-SH3  antibody  demonstrates  expression 
in many cell types, which is absent from knockout embryos 
(Fig. S2 A). Immunofluorescence labeling of wt and Mia3-
null mouse embryonic fibroblasts (MEFs) with the anti-SH3 
antibody reveals punctate staining peripheral to the nucleus 
only upon permeabilization and only in wt cells (Fig. 1 D). 
The C-terminal antibody gives a similar pattern of staining 
(Fig. S2 B), and the signal from the two antibodies is perfectly 
colocalized (Fig. S2 C).
Table I.  Onset and penetrance of the Mia3-null phenotype
Stage Wt Heterozygote Homozygote Null allele
dpc %
10.5 12 22 11 24.4
12.5 49 95 43 23
13.5
a 81 162 87 26.4
14.5 92 212 86 22.1
15.5
b 63 110 44 20.3
16.5 10 13 6 20.7
18.5 10 19 14 32.6
Embryo recovery and genotype distribution from Mia3
+/ heterozygous intercrosses collected from 10.5–18.5 dpc.
aDifferences first apparent by marker analysis.
bOvert phenotype first apparent (100% penetrance).JCB • VOLUME 193 • NUMBER 5 • 2011   938
and they are restricted to the marrow cavity immediately under-
lying the Mmp9-positive perichondrium (Fig. 3, E and G). 
Thus, the absence of secondary mineralization is caused by   
severe defects in vascular invasion and recruitment of osteo-
blasts in Mia3 mutants. We hypothesized that this was caused 
by a general delay in chondrogenic maturation and focused our 
further analysis on this.
Histological analysis confirmed the chondrogenic delay 
and highlighted defects in chondrocytic ECM deposition. Carti-
laginous templates of the bone first become morphologically 
distinct in the Mia3 mutants at 13.5 dpc (Fig. 3, I and J). In con-
trols, Masson’s trichrome stain reveals collagen deposition typi-
cal of maturing chondrocytes that begin to secrete increasing 
amounts of collagen and other structural proteins in the ECM 
(Fig. 3 I; Kronenberg, 2003). However, very little stain is seen 
in the mutants (Fig. 3 J). This is not simply because of a delay 
in cellular differentiation, as the ECM stain surrounding the   
hypertrophic cells is still significantly reduced in the mutant 
embryos at 15.5 dpc (Fig. 3, K and L). Mineralized bone collar, 
which is stained darkly blue, is embedded in the perichondrium 
of controls at this stage but missing from the mutants. Hema-
toxylin and eosin–stained sections of Mia3
/ humeri show a 
complete absence of well-defined trabeculae seen at the diaphy-
sis of controls (Fig. 3, M and N). Ki67 labeling of 14.5-dpc   
humeri indicates that chondrocytes populating the resting and 
proliferative zones maintain their proliferative capacity in the 
knockout mice (Fig. 4, A, B, and I). However, consistent with 
the arrest in chondrogenic progression, dying TUNEL-positive 
cells are completely absent from the center of the mutant bone 
(Fig. 4, E and F). By 16.5 dpc, the majority of cells residing 
Alizarin red/Alcian blue–stained skeletal preparations show that 
relative position and numbers of skeletal elements are normal, 
but a delay in the onset of mineralization is apparent at 13.5 dpc 
(Fig. 2, E and F), and there is an almost complete lack of calcium 
deposits at 15.5 dpc (Fig. 2, G and H), a time when the majority 
of skeleton components have initiated primary mineralization.
Residual mineral deposition is apparent in the dwarfed 
mutants at 18.5 dpc (Fig. 2, I and J), but microcomputed to-
mography  (micro-CT)  fails  to  detect  ossified  tissue,  which 
would indicate secondary mineralization in the mutants (n = 3;   
Fig. 2, K and L). Secondary mineralization is driven by osteo-
blasts, and indeed, Mia3 mutants have a severe reduction in 
osteopontin  (Spp1)-positive  osteoblasts  at  14.5  dpc  (Fig.  3,   
A and B) and show no detectable staining for osteoblast-derived   
Col1a1 and Igfbp6 (insulin-like growth factor–binding protein)   
in the perichondrium at this stage (not depicted). The few osteo-
blasts observed in the mutant bones were found primarily in   
the periphery of the perichondrium adjacent to the hypertrophic 
region at the middle of the condensation (Fig. 3 B). In the con-
trols, these cells are well entrenched in the perichondrium and 
have invaded the remodeling matrix of the hypertrophic zone 
by 14.5 dpc (Fig. 3 A). Expression of Mmp9 (matrix metallo-
peptidase 9), a secreted ECM-degrading enzyme, which primes 
the mineralized matrix for vascular invasion (Vu et al., 1998),   
is strongly down-regulated (Fig. 3, C and D), and MECA-32– 
positive vessels are not apparent in the mutant hypertrophic 
zone. Clearly, the dependence of osteoblasts on Mia3 is not 
absolute, and by 16.5 dpc more, osteoblasts are apparent within 
the center of each bone, although their numbers are still drasti-
cally reduced with respect to wt littermates (Fig. 3, F and H),   
Figure 2.  Mia3
/ embryos are dwarfed, edemic, and fail to form a mineralized skeleton. (A and B) Mia3 mutant embryos display a shortening of the 
snout and limbs at 16.5 dpc. (C and D) Mia3 mutant embryos are significantly dwarfed at 18.5 dpc. (E and F) Alizarin red–positive skeletal mineraliza-
tion initiates within the intramembranous bone of the jaw and endochondral bones of the clavicles of 13.5-dpc wt embryos (arrows) but is absent from the 
Alcian blue–positive cartilage anlagen of Mia3 mutants. (G and H) Mineralization is advanced in nearly all axial and appendicular elements in 15.5-dpc 
control embryos but is profoundly delayed in the Mia3-null skeleton. (I–L) Calcified matrix is apparent in the bones of 18.5-dpc knockout animals (I and J), 
but micro-CT (n = 3) maximum intensity projections highlight complete absence of the mature ossified skeleton (K and L). Bars, 1 mm.939 Collagen disruption in Mia3
/ mice • Wilson et al.
expressed by these cells and required for proper chondrocyte 
maturation (St-Jacques et al., 1999; Long et al., 2001). Despite 
the delay in chondrogenic maturation, Ihh and its downstream 
target/effector gene Ptc (patched) are correctly restricted to the 
proliferating  chondrocytes  and  perichondrium  (Fig.  4,  P–S). 
Expression of the parathyroid hormone–related protein recep-
tor Pth1r, normally restricted to prehypertrophic cells, further 
confirms the overall delay in chondrocyte maturation (Fig. 4, 
T and U). The delay was substantiated by microarray analysis 
comparing 14.5-dpc wt and mutant limb buds (Fig. 4, V and W).   
Thus,  we  conclude  that  major  signaling  axes  involved  in   
chondrocytic maturation are preserved in Mia3-null bones de-
spite profound defects in chondrocytic differentiation.
The preservation of major signaling pathways in the mu-
tant led us to assess the role of Mia3 in chondrocyte differentia-
tion more directly. We generated primary MEFs from mutant 
and wt embryos, cultured them under chondrogenic conditions 
for 2 wk, and assessed the expression of Col2a1 and Col10a1 
by TaqMan PCR (Fig. S3, A and B). Col2a1 is ordinarily expressed 
internal to the bone collar are Ki67 positive, whereas in the mu-
tant, the terminally differentiated chondrocytes remain unlabeled 
(Fig. 4, C and D), and a small number of these are now TUNEL 
positive (Fig. 4, G and H). Dying cells are not apparent elsewhere 
in the mutant bone. Thus, the generalized dwarfing of the knock-
out skeleton is driven primarily by the delay and arrest of chon-
drogenic maturation, lack of vascular recruitment, and the failure 
to elaborate a primary ossification center in Mia3 mutants.
We characterized the delay in chondrogenic progression 
by examining the expression of chondrocyte differentiation mark-
ers and major signaling pathways involved in chondrogenesis. 
At 14.5 dpc, mature hypertrophic chondrocytes expressing 
Col10a1 (collagen type X) in the absence of Col2a1 (collagen 
type II) and Col9a1 (collagen type IX) are evident at the center 
of the control bone anlagen, whereas adjacent prehypertrophic 
cells express all three collagens (Fig. 4, J–O). Col10a1 expres-
sion initiates in the center of the Mia3 mutant bone as well, 
but these cells also maintain expression of Col2a1 and Col9a1 and   
are, thus, in the prehypertrophic stage. Ihh (Indian hedgehog) is also 
Figure 3.  Osteogenesis is compromised by the delay in chondrogenic progression and vascular recruitment in Mia3-null bone. (A and B) In contrast 
to wt embryos, rare Spp1-positive osteoblasts (arrows) are present in the perichondrium of the Mia3
/ humerus at 14.5 dpc. (C and D) Mmp9 and 
PLVAP/MECA-32 are restricted to a few cells within the perichondrium of Mia3
/ bones at 14.5 dpc. (E and G) At 16.5 dpc, Mmp9-positive cells remain 
restricted to the presumptive bone collar perichondrium of Mia3 mutant embryos. (F and H) A small number of Spp1-positive osteoblasts reside within 
the hypertrophic zone. (I–N’) Masson’s trichrome stain (I–L) and hematoxylin/eosin stain (M and N) of wt and Mia3-null humeri at 13.5, 15.5, and 18.5 
dpc highlight the onset and progression of the chondrodysplastic phenotype. Boxed regions (I–N) are enlarged to the right of each set of panels (I–N).   
Bars, 100 µm.JCB • VOLUME 193 • NUMBER 5 • 2011   940
chondrocyte-enriched primary cell cultures derived from 14.5-
dpc Mia3
/ ribcages show a similar accumulation of Col2a1 
and, to a lesser extent, Col3a1 within the cells (Fig. 5, B and C).   
Although some collagen is deposited outside of the knockout 
cells,  it  appears  to  be  abnormally  aggregated  and  unevenly 
dispersed throughout the extracellular fibrils. Quantitation of 
total  cell-associated  collagen  using  SDS-PAGE  and Western 
blot analysis confirmed these observations, with 2.2–4.7-fold 
increases in the amount of Col1, Col3a1, and Col9a1 in Mia3-
null MEFs relative to controls (Fig. S3, G–I) despite normal lev-
els of transcription (Fig. S3 C). To confirm that these changes 
were driven by increased retention, we compared ECM-resident 
versus cell-associated levels of Col1 in chondrocytes and MEFs 
(Fig. 5 D). A 50% reduction is observed in the amount of ECM-
deposited Col1 in Mia3-null primary chondrocytes (Fig. 5 E, 
P = 0.006, n = 3 per genotype). In MEFs, cell-associated Col1 
by all nonhypertrophic chondrocytes, whereas Col10a1 expres-
sion initiates in prehypertrophic cells and remains up-regulated in 
mature hypertrophic cells. As anticipated, the onset and amplitude 
of expression of both collagens in Mia3
/ cells lagged behind 
those of controls. We therefore conclude that Mia3 is required 
specifically within chondrocytes for their timely maturation.
Consistent with the observation that Col7a1 binds MIA3 
and accumulates in cells in which MIA3 transcripts are re-
duced by RNAi knockdown (Saito et al., 2009b), comparisons 
of Col7a1 deposition between wt and Mia3
/ MEFs with and 
without membrane permeabilization reveal a slight reduction in   
the overall amount of extracellular collagen secreted by the   
null cells and a dramatic intracellular accumulation of Col7a1   
adjacent to the nucleus (Fig. 5 A). The profound and cell- 
autonomous defects in chondrocyte differentiation, however, 
suggest a broader role for Mia3 than secretion of Col7a1. Indeed, 
Figure 4.  Early chondrocyte proliferation, differentiation, and critical patterning pathways are preserved in 14.5-dpc humeri despite abnormal chon-
drocyte morphology in Mia3
/ embryos. (A–D) Ki67 labeling of 14.5-dpc (A and B) and 16.5-dpc (C and D) humeri demonstrate normal proliferation 
of mutant chondrocytes. RZ, PZ, PHZ, and HZ denote resting, proliferative, prehypertrophic, and hypertrophic zones, respectively. (E and F) The majority 
of terminally differentiated hypertrophic chondrocytes are TUNEL positive in wt 14.5-dpc humeri (E), whereas Mia3-null hypertrophic chondrocytes fail to 
die (F). (G and H) Scattered dying cells are restricted to the hypertrophic zone in 16.5-dpc wt and Mia3-null humeri (red brackets). (I) Ki67-positive (+ve) 
cells within the proliferative zone. Mean values are presented, and SEM is shown from two independent wt samples and three Mia3
/ humeri with 4–10 
sections/animal. (J–U) Section in situ analysis comparing expression of Col9a1, Col2a1, Col10a1, Ihh, Ptc, and Pth1r between wt and Mia3-null 14.5-dpc 
humeri demonstrates an intact Ihh and Pth1r signaling axis despite dysmorphism of the cartilage. (V and W) Comparison of 14.5-dpc wt and Mia3
/ 
forelimb RNA on Mouse Genome 430 v2.0 arrays (Affymetrix) reveals an overall reduction in genes associated with chondrogenic progression (V) and 
osteoblast expansion (W; n = 5 per group, P < 0.05). Expression values are represented as colors, in which the range of colors (red, pink, light blue, and 
dark blue) shows the range of expression values (high, moderate, low, and lowest). Bars, 100 µm.941 Collagen disruption in Mia3
/ mice • Wilson et al.
Figure 5.  Abnormal collagen glycosylation, secretion, maturation, and ECM deposition in Mia3-null cells. (A–C) Immunofluorescent staining of wt and 
Mia3
/ primary MEFs (A; Col7a1) and chondrocytes (B and C; Col2a1 and Col3a1) reveals abnormal punctate ECM deposition (asterisks) and an 
increase in ER-retained collagen upon cell permeabilization. Bars, 10 µm. (D and E) Comparison and quantitation of ECM and cell-associated collagens 
isolated from wt and Mia3-null chondrocytes (left) and MEFs (right). Values are ± SEM. n = 3 per genotype. KO, knockout. (F) Western blot analyses of cell-
associated collagen 1 (Col1) from wt and Mia3
/ MEFs show substantial changes in collagen processing in null cells. Distribution plots summarize data 
(n = 4 per genotype). Arrows indicate processed collagen types. (G) Timed protease digestion of embryonic lysates blotted for Col2a1 further highlights 
the presence of alternately modified collagen (arrows and boxed region) in Mia3-null tissues. Molecular masses are given in kilodaltons.JCB • VOLUME 193 • NUMBER 5 • 2011   942
actin (Fig. 6, Q and R) demonstrates that Col4a1 accumulation 
occurs in both endothelial cells and mural cells. Col4a1 is a   
major component of the basement membrane of numerous other 
tissues, and cells nestled between the muscle fibers in Mia3 
knockouts also contain prominent intracellular aggregates of 
Col4a1 that are absent in controls (Fig. 6, S and T). In contrast, 
deposition of fibronectin and aggrecan, 440-kD and 2,500-kD 
ECM proteins, is unaffected, and intracellular accumulation is 
not observed in vivo (Fig. S4). Fibronectin fibrils are extra-
cellular in the chondrocytes (not depicted) and limb mesenchyme 
(Fig. S4, A and B). Colabeling of WGA and aggrecan also 
shows strong extracellular staining (Fig. S4, C and D). Comp 
(cartilage oligomeric matrix protein), an extracellular collagen-
associated protein that has been shown to facilitate fibrillogene-
sis (Zaucke and Grässel, 2009), also aggregates within the ER 
of Mia3-null chondrocytes (Fig. 6, U–X). However, it is diffi-
cult to ascertain whether this is a direct effect. Accumulation of 
intracellular COMP can result in the coretention of interacting 
partners, including Col9a1 (Holden et al., 2001), and the reverse 
phenomenon may be driven by the collagen accumulation in 
Mia3 mutant cells. We conclude that Mia3 does not play a gen-
eral role in facilitating the export of all ECM proteins but, rather, 
is required for normal collagen secretion and deposition in   
numerous tissues, including, but not limited to, the bone, skin, 
muscles, and developing vasculature.
To further investigate how protein accumulation affected 
Mia3 mutant cells, we performed transmission EM (TEM) analy-
sis of developing chondrocytes. TEM revealed marked disten-
sion of the ER in Mia3 mutants (Fig. 7, A–D), which is consistent 
with ER accumulation of collagens in these highly secretory 
cells. Furthermore, it is well recognized that abnormal accumu-
lation of misfolded proteins in the ER causes ER stress, which 
triggers the response of the ER quality control system (Ma and 
Hendershot, 2004). Given the distended ER revealed by TEM 
and immunofluorescent detection of increased and apparently 
aggregated collagens in mutant cells, we hypothesized that the 
unfolded protein response (UPR) might be induced.
Consistent with these morphological changes, gene ex-
pression profiling by the microarray of wt and Mia3
/ forelimb 
RNA collected from 12.5-, 13.5-, and 14.5-dpc embryos (n = 5 
per genotype) reveals a highly significant increase in genes as-
sociated with the UPR (Fig. 8 A). These include primary drivers 
of the UPR, such as CHOP and ATF4, as well as numerous 
downstream  targets,  including  Grp78/BiP  (binding  immuno-
globulin protein), Atf5, and Dnajb9. Mediators of ER-associated 
degradation (ERAD), such as Derl1 and Edem1, are also highly 
up-regulated. The majority of these genes are expressed at nor-
mal (low) levels at 12.5 dpc, but their expression begins to di-
verge from wt littermates at 13.5 dpc (Fig. 8, B and C). This 
trend was maintained at 14.5 and 16.5 dpc (Fig. S5).
In situ expression analysis of the primary UPR effectors 
Atf4, Atf5, and CHOP1 as well as two targets of the Atf4–CHOP 
pathway, Chac1 and Trb3 (tribbles homologue 3; Ohoka et al., 
2005; Mungrue et al., 2009) reveals specific up-regulation of 
the  UPR  throughout  the  chondrocytes  of  the  14.5-dpc  limb   
(Fig. 8, D–M). Extremely low levels of Atf4 and Atf5 near the 
limit of detection were noted in scattered control prehypertrophic 
is increased twofold in Mia3-null cells (P = 0.05), whereas the 
level of ECM-associated collagen is barely detectable and not 
significantly different (Fig. 5 E). We conclude that the transit of 
several collagens is hampered by the loss of Mia3, and reduced 
levels are deposited within the ECM.
These analyses also reveal a pronounced alteration in 
the maturation of these collagens in embryo and MEF lysates 
(Fig. 5 F and Fig. S3, D–I). Newly synthesized molecules 
of procollagen are co-translationally transferred into the ER 
and modified, and the N-terminal and C-terminal propeptides 
(N- and C-propeptides) are processed from the collagen heli-
ces during or immediately after secretion by the N-terminal 
proteinase (N-proteinase) Adamts2 and the C-terminal pro-
teinase (C-proteinase) BMP1, respectively (Dombrowski and 
Prockop, 1988; Li et al., 1996). In Mia3-null MEFs, the pro-
collagen forms of Col1a1 and Col1a2 are readily distinguish-
able and highly enriched when compared with control lysates 
(Fig. 5 F). These shifts are also observed in embryonic tissue 
lysates (Fig. S3 E). Enrichment for alternately migrating spe-
cies of Col3a1 and Col9a1 is also observed in knockout tissues 
and MEFs (Fig. S3, F–I), but the exact nature of these forms 
is unresolved. Deglycosylation with peptide-N-glycosidase F 
(PNGase F) reduces the largest Col1 band (Fig. S3 E), sug-
gesting that this is a modified glycoform, and protease-resistant 
Col2a1 fragments also display altered migration in mutant em-
bryo lysates (Fig. 5 G). These fragments are not detected when 
samples are predigested with PNGase F (unpublished data), 
demonstrating that these indeed represent protease-resistant 
glycoforms. A similar shift in collagen mobility, driven by   
altered glycosylation and propeptide cleavage, is also observed 
in cells and tissues lacking the collagen chaperone Hsp47   
(Nagai et al., 2000; Ishida et al., 2006). These biochemical 
analyses are consistent with a delay in the maturation and 
secretion of several collagens.
To evaluate collagen secretion defects in vivo, we looked 
at the distribution of collagen in the developing bone at 14.5 dpc. 
Col2a1 is highly expressed, but extracellular staining is signifi-
cantly reduced and accompanied by intracellular accumulation 
in the knockout animals (Fig. 6, A–D). Expression of Col3a1, 
a prototypical fibrillar collagen, is significantly up-regulated in 
the mutant chondrocytes but is only detectable intracellularly 
rather than in the ECM (Fig. 6, E and F). Col1, another fibrillar 
collagen, is abundantly expressed in the mutant but mislocal-
ized to an intracellular compartment (Fig. 6, G and H). Costain-
ing of the plasma membrane with WGA further emphasizes the 
significant reduction of Col1 incorporation into extracellular 
collagen fibrils (Fig. 6, G and H).
Because Mia3 is broadly expressed in all tissues through-
out development, we examined the distribution of collagens and 
other large ECM molecules in other tissues. Col1 and Col3a1 
are expressed outside of the bone in skin and the underlying 
mesenchymal cells. In contrast to the fibrillar staining in control 
mesenchyme, numerous Mia3
/ cells contained intracellular 
aggregates of these collagens (Fig. 6, I–L). Intracellular accu-
mulation  of  Col4a1  is  apparent  throughout  the  developing 
Mia3
/ vasculature (Fig. 6, M and N), and colabeling with   
antibodies against MECA-32 (Fig. 6, O and P) and smooth muscle 943 Collagen disruption in Mia3
/ mice • Wilson et al.
Figure 6.  Collagen and Comp retention and reduced fibril formation in Mia3-null embryonic tissues. (A–H) Matrix deposition of Col2a1 (A–D), Col3a1 
(E and F), and Col1 (G and H) is reduced around chondrocytes within 14.5-dpc Mia3-null bones. Boxed regions are enlarged in adjacent panels. 
Col2a1 overlaps exclusively with the ER marker Hsp47 in null chondrocytes (C and D), with similar results seen with Col1 and Col3a1 (not depicted).   
(G and H) WGA labeling of the plasma membrane reveals intracellular accumulation of Col1 in null cells. Yellow arrows in all panels highlight these col-
lagen aggregates. (I–L) Deposition of Col1 (I and J) and Col3a1 (K and L) within collagen fibrils is reduced in Mia3-null subdermal mesenchymal cells with 
associated intracellular accumulation. (M and N) Vascular Col4a1 is present within intracellular aggregates in the Mia3 knockouts. (O–R) Colabeling of 
Col4a1 and MECA-32 (O and P) or smooth muscle actin (Q and R) demonstrates abnormal collagen accumulation within both endothelial (yellow arrows) 
and mural cells (pink arrow) of the limb vasculature. (S and T) Col4a1 is disrupted in the basement membrane of the Mia3 mutant muscle. (U–V) Comp 
is predominantly ECM associated in wt hypertrophic chondrocytes (enlarged in U) and resting chondrocytes (U) of the 14.5-dpc humerus, whereas in 
Mia3
/ cartilage condensates, COMP is found both within and without the hypertrophic chondrocytes (V) and is predominantly intracellular in the growth 
plate (V). (W–X) Antibody labeling of Comp intracellular aggregates (W and X) and Col2a1 aggregates (W and X) within Mia3-null chondrocytes 
overlaps (W and X) with cell-retained Col2a1, indicating that both factors are trapped within the ER. Bars: (A–T and W–X) 10 µm; (U–V) 100 µm.
cells (Fig. 8, D and F; and not depicted) as well as dermal fibro-
blasts. These general trends in expression also hold true at 16.5 
dpc (Fig. S5) with two exceptions: Atf5 becomes apparent in the 
knockout epidermis and dermis (Fig. S5 L), and CHOP1 expres-
sion also becomes significantly up-regulated in the Mia3-null 
prehypertrophic chondrocytes (Fig. S5 M). These results were JCB • VOLUME 193 • NUMBER 5 • 2011   944
The  Mia3  mutant  phenotype  indicates  a  high  level  of 
specificity in the selection, packaging, and exit of cargo from 
the ER. Our analysis provides direct evidence that Mia3 is   
required for proper secretion of all three primary classes of   
collagens. These include interstitial fibrillar collagens (I, II, and 
III), a nonfibrillar basement membrane collagen (IV), and a 
FACIT (fibril-associated collagen with interruptions in triple 
helix; IX). The fibrillar collagens are major constituents of the 
ECM that support body structure. Nonfibrillar Col9a1 is exclu-
sively found in basement membranes and provides a scaffold 
for other ECM components. FACITs associate with the sur-
faces of fibrillar collagens and mediate their interactions with 
other ECM proteins. Although distinct in structure, function, 
and  localization,  each  of  these  collagen  classes  contain  the 
characteristic Gly-X-Y triplet repeats that drive the formation 
of the unique collagen triple helix. Because the N-terminal lu-
minal SH3 domain of Mia3 was shown to bind to Col7a1 (Saito 
et al., 2009b), we believe this domain, or an associated protein, 
recognizes the triple helical collagen motif and is responsible 
for collagen specificity.
further  corroborated  at  16.5  dpc  using  UPR  PCR  arrays   
(Fig. S5 O). Thus, we see a relatively uniform up-regulation of 
UPR  genes  throughout  the  Mia3-null  cartilage  template  at   
14.5 dpc, a pattern that is maintained through 16.5 dpc.
Discussion
We have found that loss of function of the ER-resident protein 
Mia3  leads  to  developmental  defects  primarily  affecting  the   
embryonic skeleton and skin (Fig. 9). We demonstrate that in 
mutant embryos and primary cell lysates, secretion of numerous 
collagens, including collagens I, II, III, IV, VII, and IX, is dis-
rupted, most likely because of defective export from the ER. 
Collagen fibrils, though dispersed and diminished in number, 
are present in the knockout ECM, and a reduced amount of 
ECM-associated collagen is discernible by Western blotting and 
immunofluorescence. This reduction, in turn, leads to a delay in 
chondrogenesis, and the embryonic null phenotype resembles 
an amalgam of chondrodysplastic disorders arising from defec-
tive collagen folding, deposition, and/or maturation.
Figure 7.  The endoplasmic reticulum is grossly distended, and collagen fibrils are reduced in knockout chondrocytes. (A–D) Comparative TEM images of 
wt (A and C) and Mia3 mutant (B and D) proliferative zone chondrocytes within the humerus. ER distention is clearly evident in the majority of null cells 
along with a concomitant reduction in extracellular collagen fibril assembly (asterisks). Nuc, nucleus.945 Collagen disruption in Mia3
/ mice • Wilson et al.
divergence, other members of the Mia family are also suggested 
to have roles regulating chondrogenesis. For example, Otor  
expression is restricted to the cartilaginous cells of the developing 
cochlea (Robertson et al., 2000) and required for their differentia-
tion (Cohen-Salmon et al., 2000). Similarly, Mia1 is expressed 
exclusively in the developing skeleton, and Mia1-null mice are   
viable and display subtle ultrastructural defects in collagen fibril   
Mia3 is a member of a gene family defined by the unique 
presence of an extracellular SH3 domain. The other three fam-
ily members encode small (100 amino acid) secreted proteins 
(Mia1, Mia2, and Otor; Lougheed et al., 2001). Work by Saito 
et al. (2009b) as well as our own experiments indicates that the 
ER-resident Mia3 represents a divergent, membrane-anchored 
member of this gene family. Interestingly, despite this structural 
Figure 8.  The UPR is up-regulated in chondrocytes of Mia3-null animals coincident with delayed bone maturation. (A) Gene expression in wt and Mia3-null 
14.5-dpc limbs (n = 5 each) was studied by Mouse Genome v2.0 arrays (Affymetrix) with probes for over 39,000 transcripts. Using unsupervised gene 
ontology analysis (Broad Institute, Cambridge, MA), over-represented patterns of genes associated with ER and Golgi function/UPR/ERAD were identified. 
All data presented have a P < 0.05. (B and C) Comparison of array data for several probes specific to chondrogenic/osteogenic progression (B; Col10a1, 
Dmp1, Ibsp, and Spp1) and UPR/ER stress (C; Atf4, Atf5, Ddit3, Chac1, Eif4ebp1, Creb3, Hspa5, and Slc7a3) in 12.5-, 13.5-, and 14.5-dpc whole 
forelimbs. Misregulation of both gene sets in mutants is concomitant at 13.5 dpc. Col10a1 and the UPR gene set are significantly misregulated (P < 0.05) 
at 13.5 dpc, whereas the osteogenic markers Dmp1, Ibsp, and Spp1 achieve significance at 14.5 dpc. GEO Datasets accession numbers are given at 
the top. (D–M) Section in situ hybridization of 14.5-dpc humeri from wt and Mia3-null embryos using probes against Atf4, Atf5, Ddit3, Chac1, and Trib3 
reveals prominent staining throughout all chondrocytes in comparison to controls. D–M denotes close-ups from the humeri shown in D–M. Bars, 100 µm.JCB • VOLUME 193 • NUMBER 5 • 2011   946
in Sec13, Sec23, and Sec24 cause chondrodysplastic phenotypes 
(Boyadjiev et al., 2006; Lang et al., 2006; Fromme et al., 2007; 
Townley et al., 2008; Ohisa et al., 2010; Sarmah et al., 2010).   
In each of these genetic models, collagen export in mutant carti-
lage is blocked and the ER becomes engorged, but transport and 
secretion of smaller proteins remain unchanged. Because the   
interaction of SEC24C is hypothesized to be critical for MIA3- 
facilitated loading into ER export vesicles (Saito et al., 2009b), 
we suggest that the proper coupling of Sec13–Sec31 to Sec23–
Sec24 is required for the secretion of large macromolecular cargo 
from  the  ER.  Chondrocytes,  because  they  secrete  substantial 
amounts of ECM, are especially sensitive to perturbations in pro-
tein traffic. Therefore, it is intriguing that we have identified a 
shorter isoform of Mia3 that consists of only the transmembrane 
and C-terminal Sec24c-interacting domains. Expression of this 
isoform is not disrupted in our mutant, and we can only speculate 
about its function. Because it lacks the collagen-interacting SH3 
domain, it may serve to modulate or sequester Sec24c rather than 
directly regulating collagen export from the ER.
assembly (Moser et al., 2002). Recombinant Mia1 binds to the   
ECM components fibronectin and laminin and shows an affinity 
for tenascin and Col9a1 (Bosserhoff et al., 2003). Each of these 
proteins contains a characteristic exposed arginine-glycine-
aspartic acid tripeptide-repeating motif (a specific derivative of 
the Gly-X-Y collagen helical motif), and purified Mia1 can bind 
this motif in isolation. We suggest that the unique MIA fam-
ily SH3 fold represents a conserved motif that has evolved to 
modulate  collagen  metabolism  both  within  the  cell,  during 
packaging and secretion, as well as outside of the cell, during 
incorporation into the ECM.
Distinct from the other Mia proteins, Mia3 has a hydropho-
bic transmembrane domain and C-terminal proline-rich region. 
The C-terminal domain interacts with SEC24C, a core compo-
nent of the COPII coat protein complex. The COPII complex is 
responsible for the initiation of vesicle formation, cargo selec-
tion,  polymerization,  and  release  of  loaded  carriers  from  ER 
membranes (Barlowe et al., 1994). COPII consists of five core 
proteins (Sar1, Sec13, Sec31, Sec23, and Sec24), and mutations 
Figure  9.  A  schematic  for  the  interaction 
between  Mia3  and  the  UPR  machinery  in 
regulating  collagen  metabolism  as  modeled 
in chondrocytes. (A) In wt animals, the nor-
mally low levels of UPR regulators are suffi-
cient to handle the increase in protein load 
during chondrocyte maturation. (B) The loss 
of Mia3 rapidly leads to buildup and reten-
tion of collagen within the ER and initiates a 
strong and sustained UPR that is sufficient to 
slow cellular differentiation and prevent gen-
eralized apoptosis.947 Collagen disruption in Mia3
/ mice • Wilson et al.
below PERK and Eif2, is also required for osteoblast differen-
tiation and function (Yang et al., 2004). Combined activation 
of Ire1, PERK, and ATF6 produces cytoprotective outputs, 
such as reduced translation, enhanced ER protein-folding ca-
pacity, and clearance of misfolded ER proteins along with 
proapoptotic outputs, such as CHOP production. Although CHOP 
is up-regulated in the prehypertrophic chondrocytes of Mia3 mu-
tants, we believe that the simultaneous up-regulation of Ire1  
(as indicated by its targets Grp78/BiP and DNAJB9) and Atf6 
(Fig. 9) is cytoprotective, and apoptosis is averted early in the 
elaboration of the phenotype (Fig. 4, E–H). However, the develop-
mentally arrested chondrocytes begin to succumb and show evi-
dence of apoptosis and necrosis by 18.5 dpc (Fig. 3, N and N).
BBF2H7  is  another  ER  resident  basic  helix-loop-helix 
transcription factor that is highly expressed in chondrocytes, 
activated by ER stress, and is, itself, an activator of Sec23a 
expression (Kondo et al., 2007). Thus, acting via Bbf2h7, ER   
stress can activate ER to Golgi trafficking, specifically in 
the cartilage, and this induction is required to handle normal   
ECM protein load in chondrocytes. Intriguingly, Bbf2h7
/ mice 
are phenotypically indistinguishable from Mia3
/ mice (Saito   
et al., 2009a).
Recent association studies have demonstrated a link be-
tween polymorphisms at the MIA3 locus and early onset MI 
(Samani et al., 2007; Kathiresan et al., 2009). The underlying 
pathobiology of MI is a buildup of atherosclerotic plaques on the 
walls of major vessels, with plaque rupture and ensuing throm-
bosis being responsible for the majority of cases (Schoenhagen 
et al., 2002). Collagens constitute 60% of the protein of an   
atherosclerotic plaque (Smith, 1965), and the collagen-rich 
fibrous cap covering the lipid-dense core of the atherosclerotic 
plaque is the major factor in its stability (Adiguzel et al., 2009). It 
is exciting then that our experiments provide a plausible biologi-
cal mechanism and potential model for MIA3’s involvement in 
MI. An imbalance between collagen synthesis and degradation 
by macrophage- and smooth muscle cell–associated proteinases 
could lead to cap thinning, degradation of the collagen IV– 
enriched basement membrane, and plaque instability. A straight-
forward prediction from our studies is that a reduction in MIA3 
expression would tilt the balance toward a thinner cap and an 
unstable plaque.
Materials and methods
Animals
Mia3
+/ mice were backcrossed and maintained on a C57BL/6 back-
ground. Intercrosses between heterozygous offspring were used to obtain 
Mia3
/ embryos. Yolk sac– or embryonic tissue–derived genomic DNA 
was genotyped by PCR in which primers specific for wt or mutant alleles 
were combined in the same reaction. Genotyping of Mia3 knockout mice 
was performed by PCR using primers directed against neomycin, 5-GCA-
GCGCATCGCCTTCTATCG-3; intron 1, 5-AAGACCGTGTCTGTGGCT-
CAG-3;  and  intron  2,  5-GCACCACCACCACCAAGAGTT-3,  which 
generates a 380-bp product in the wt and a 232-bp product in the knock-
out allele. The reaction conditions were 94°C for 4 min followed by 30 cy-
cles at 94°C for 30 s (denaturing), 62°C for 1 min (annealing), and 72°C 
for 1 min (extension). Noon of the day of vaginal plug detection was 
termed 0.5 dpc. All animals were handled in accordance with protocols 
approved by the Genentech Institutional Animal Care and Use Committee. 
Mouse colonies were maintained in a barrier facility at Genentech, con-
forming to California state legal and ethical standards of animal care.
The presence of high molecular mass forms of collagen in 
Mia3-null lysates (Fig. 5 and Fig. S3) supports our hypothesis 
that processing (cleavage) of collagen propeptides is impaired in 
Mia3-null cells, much as it is in Hsp47-null mice (Nagai et al., 
2000; Ishida et al., 2006). The clearest example of this phe-
nomenon is seen with Col1 in which there is a pronounced shift   
in the amount of procollagen observed in knockout cells (Fig. 5,   
E and N). In some examples of osteogenesis imperfecta, mu-
tations within the triple helical domain of COL1A1 prevent   
N-propeptide cleavage (Vogel et al., 1987, 1988), leading to sim-
ilar shifts in migration. Col3a1 and Col9a1 also display these 
mobility shifts. Higher molecular mass bands are enriched, but 
their identity remains to be clarified. We believe these differences 
are significant, especially for Col9a1, because the higher molecu-
lar mass form is consistently and dramatically enriched in Mia3-
null cells (Fig. S3 H). Thus, Mia3 is required for timely collagen 
maturation and secretion.
Clearly, Mia3 is not absolutely required for collagen secre-
tion, as not all collagens are affected to the same extent in all tis-
sues by the loss of Mia3. For example, extracellular Col2a1 fibrils 
are almost nonexistent in the null cartilage (Fig. 6, C and D), 
whereas fibrils containing Col3a1 still surround mesenchymal 
cells despite ER accumulation (Fig. 6, K and L). Our Western blot 
analyses also confirm that collagen secretion indeed still occurs 
in Mia3-null cells (Fig. 5 and Fig. S3). Either an alternate inde-
pendent pathway of egress remains open to large ECM cargoes, 
or these proteins can still exit via large COPII vesicles.
It is possible that Mia3 may also play a role in the export 
of other proteins. Recent studies reveal that the Sec24 cargo 
adapters bind preferentially to different ER export signals   
(Wendeler et al., 2007; Mancias and Goldberg, 2008), whereas 
several export signals are recognized redundantly by two or 
more of the Sec24 isoforms. The only noncollagen protein that 
we found to accumulate in the ER of Mia3-null chondrocytes is 
COMP (Fig. 7). COMP is a large glycoprotein found predomi-
nantly in the ECM of cartilage and interacts with both fibrillar 
and nonfibrillar collagens with high affinity. COMP knockout 
mice show normal development, growth, and longevity, so it is 
clearly not required for collagen secretion (Hecht et al., 1998). 
Because  collagen  ER  exit  is  disrupted  in  COMP  mutants 
(Holden et al., 2001) and both aggregate within the Mia3-null 
ER, it is likely that the retention of COMP is secondary to the 
retention of collagens.
In the absence of Mia3, collagen buildup within the chon-
drocyte ER initiates the UPR (Fig. 9). The UPR machinery is 
required not only to police misfolded proteins but also to deal 
with the episodic changes in protein load occurring during nor-
mal developmental processes. The observation that the UPR 
mediators Atf4, Atf5, and Trb3 are present, albeit at low levels, 
in normal prehypertrophic cells indicates that maturing chon-
drocytes normally induce their expression, likely because of 
the increasing demand on the ER/Golgi as chondrocytes create 
and embed themselves in a collagen-rich ECM (Eyre, 2004).   
Indeed, loss of function mutations in PERK (eukaryotic initiation 
factor 2  kinase) cause defects in highly secretory cells, such 
as osteoblasts and exocrine cells of the pancreas (Zhang et al., 
2002), and Atf4, one of the primary effectors of the UPR cascade   JCB • VOLUME 193 • NUMBER 5 • 2011   948
Cellular proliferation
Cellular proliferation was evaluated using the Tissue Studio analysis suite in 
Definiens Architect v1.3 image analysis software (Definiens AG). Regions 
of interest, defined as each growth plate of a humerus, were identified and 
manually circumscribed in digital micrographs acquired on a microscope 
(Axioskop 2 plus [Carl Zeiss]; 20× magnification and 2.4 pixels/µm) from 
10-µm paraffin sections. Two wt and three knockout animals were exam-
ined (n = between 4 and 10 growth plates per animal). Hematoxylin- 
positive nuclei were segmented and quantified, with a subset of proliferat-
ing nuclei identified using an empirically determined fixed threshold for 
DAB/Ki67 (Thermo Fisher Scientific) positivity. A proliferation index was 
then calculated as the ratio of proliferating to total nuclei in each defined 
region of interest.
TEM
The tissues were fixed in 1/2-strength Karnovsky’s fixative (2% parafor-
maldehyde and 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer, 
pH 7.2), washed in the same buffer, and postfixed in 1% aqueous osmium 
textroxide for 1 h. The samples were then dehydrated through a series 
of ethanol followed by propylene oxide and embedded in Eponate 12 
(Ted Pella). Thin sections were cut on a microtome (Ultracut E; Reichert), 
stained with uranyl acetate and lead citrate, and examined in a microscope 
(CM12; Philips). Images were captured with a retractable digital camera 
(MultiScan; Gatan).
Micro-CT acquisition and image analysis
Mouse fetuses were imaged ex vivo in a hydrated scanning tube with an 
x-ray micro-CT system (µCT 40; SCANCO Medical). The micro-CT images 
were generated by operating the x-ray tube at an energy level of 45 kV, a 
current of 177 µA, and an integration time of 450 ms. Axial images were 
obtained at an isotropic resolution of 15 µm. The micro-CT scans were 
analyzed with Analyze software (AnalyzeDirect, Inc.). Maximum-intensity 
projections and 3D surface renderings in the sagittal plane were created. 
The mouse tissue was segmented from the scanning tube and noise with a 
low threshold, whereas the mineralized skeleton was segmented from the 
rest of the fetus with a higher threshold plus an erosion–dilation.
RT-PCR and TaqMan
For RT-PCR, total RNA was isolated from embryonic day 14.5 mice using 
TRIZOL reagent (Invitrogen) and subsequent DNase treatment. RT-PCR was 
performed using an RT-PCR kit (Superscript III; Invitrogen) and using the fol-
lowing primers to demonstrate the presence of exon4 in Mia3-null embryos: 
exon1–4  forward,  5-AAAGTGGCGGGGACGAAGAG-3,  and  reverse, 
5-AAAGCACCTTCTCCATCCTCTG-3, and exon1B forward, 5-ATG-
GAAGGTGGTCCTGTTGGG-3, and reverse, 5-CCAGGGCAGTCCG-
TAAAAGTC-3, at 55°C for 30 min (cDNA synthesis) and 95°C for 2 min   
followed by 25 cycles of 95°C for 15 s (denaturation), 60°C for 30 s   
(annealing), and 68°C for 30 s (elongation). To determine whether Mia3 is 
up-regulated in response to stress, the following primers were used: Mia3 5   
forward,  5-AGCCACGGACGGCGTTTCTC-3,  and  reverse,  5-ATC-
CCCCTGCCAGTTTGTAGTA-3;  Hspa5  forward,  5-ACCTGGGTGGG-
GAAGACTTTG-3, and reverse, 5-GCTCTTCAAATTTGGCCCGAGT-3; 
and Gapdh forward, 5-ATGGTGAAGGTCGGTGTGAACG-3, and reverse,   
5-TCACCCCATTTGATGTTAGTGGG-3. Cycling conditions were as follows: 
55°C for 30 min (cDNA synthesis) and 95°C for 2 min followed by 25 cycles 
of 95°C for 15 s (denaturation), 60°C for 30 s (annealing), and 68°C for 
30 s (elongation). For TaqMan, MEFs were resuspended in growth media at 
100,000 cells per 20 µl. 20 µl of dots was plated, allowed to dry for 15 min, 
and then flooded with 1 ml growth media. 50 ng/ml BMP2 (R&D Systems) 
treatment was performed on the following day. Cells were frozen at day 0 
(no bone morphogenic protein), 1, 4, 9, and 12. RNA was then extracted 
using the RNeasy kit (QIAGEN) according to the manufacturer’s instructions. 
cDNAs were generated using the Cells-to-Ct kit (Applied Biosystems). 1 µg of 
each RNA was used per 100-µl reaction, and 10 µl of each cDNA was used   
for each TaqMan reaction. Specific TaqMan primer/probe sets are outlined 
in Table S3.
Gene expression microarray studies, analysis, and quantitative PCR
Total RNA was obtained from the forelimbs of 12.5-, 13.5-, 14.5-, and 
16.5-dpc embryos using the RNeasy Mini kit (QIAGEN). The manufac-
turer’s protocol was followed for all steps, and the optional on-column 
DNase treatment was performed. For microarray analyses, RNA was 
quantified using ultraviolet spectrophotometry. RNA was labeled for and 
hybridized to expression microarray assay (HGU133; Affymetrix) using 
standard  GeneChip  protocols  (Affymetrix).  At  each  time  point,  genes 
Cell culture
MEFs were harvested from eviscerated and beheaded 12.5 dpc embryos 
by digestion with 0.05% trypsin-EDTA in PBS overnight at 4°C, dissoci-
ated by triturating, plated (one embryo per T75), and maintained in 10% 
FBS DME with penicillin/streptomycin for 2 d. MEFs were then passaged 
for experimentation no more than five times. Primary chondrocytes were   
harvested from 14.5-dpc embryonic ribcages by digestion with 5× trypsin-
EDTA in PBS for 1 h with hard vortexing every 15 min. Subsequently, the 
solution was changed to 1 mg/ml collagenase and trypsin in 1% FBS 
DME for 6 h at 37°C. The digestion was vortexed for 30 s, debris settled 
for 3 min, and supernatant with suspended cells was plated. Media were 
changed to 5% FBS -MEM containing 1 mM -glycerolphosphate and in-
sulin-transferrin-selenium A (Invitrogen) for the duration of the experiment.
ECM harvesting
Primary chondrocytes or MEFs were harvested as described (see the previous 
paragraph)  and  grown  on  10-cm  plates  for  10  or  3–4  d,  respectively.   
50 µg/ml ascorbic acid (Alfa Aesar) was added fresh to the media each day 
to stimulate collagen transcription. To produce cell lysates, cells were incu-
bated for 15 min at 37°C with 1 ml of either 1-M NaCl or 0.5% deoxycho-
late in PBS and sonicated. Plates were washed several times with 0.5% 
deoxycholate at 37°C followed by ice-cold PBS to remove all cells and ECM 
extraction buffer (5% SDS and 100 mM Tris, pH 6.8) for 15 min. ECM was 
scraped from the plate and heated at 96°C for 10 min. Protein concentrations 
of cell lysates were determined using bicinchoninic acid reagent (Thermo 
Fisher Scientific). For analysis by Western blotting with anticollagen anti-
bodies (Table S1), equal amounts of ECM were calculated based on cell ly-
sate concentrations, and equal quantities of cell lysate samples were loaded.
Histology
For all section in situ and histological/immunohistological analyses, mouse 
embryos were fixed by immersion in 4% paraformaldehyde in PBS and 
processed for paraffin sections at 10 µm. Masson’s trichrome stain and 
regressive hematoxylin and eosin stains were run on samples collected in   
Bouin’s fixative as per standard protocols. Alcian blue/Alizarin red skel-
etal preparations were processed as previously described (Solloway et al., 
1998).  For  immunofluorescent  and  immunohistochemical  staining,  the 
primary antibodies used are outlined in Table S1, fluorescent secondary   
antibodies were conjugated with Alexa Fluor 488 or 549 (1:500; Invit-
rogen), and peroxidase staining was visualized using the Vectastain ABC   
kit (Vector Laboratories), whereas rabbit antibodies were visualized with 
DAB (Thermo Fisher Scientific) using the EnVision Plus system (Dako). In situ 
hybridizations  were  performed  essentially  according  to  the  textbook 
method with minor modifications for slides. Preparation of digoxigenin- 
labeled RNA probes was performed according to the manufacturer’s in-
structions (Roche). Antisense riboprobes were constructed using the follow-
ing templates: Col9a1, Chac1, Pth1r, Trb3, Ddit3/Chop, Atf4, and Atf5. 
Specific information is outlined in Table S2. The probes for Ihh and Ptc were 
gifts from A. McMahon (Harvard University, Cambridge, MA), whereas 
Col2a1, Col10a1, and osteopontin were gifts from H.M. Kronenberg (Mas-
sachusetts General Hospital, Harvard Medical School, Boston, MA).
Section TUNEL was performed using a colorimetric kit (DeadEnd; 
Promega). BrdU cell proliferation analysis was performed as previously de-
scribed (Kim et al., 2001). Image capture of section in situ hybridization 
and immunohistochemistry was performed using differential interference 
contrast microscopy on a microscope (Axioskop Plus; Carl Zeiss). Bright-
field and dark-field image capture of whole-mount embryo and skeletal 
preparations  were  accomplished  using  a  stereomicroscope  (Discovery.
V12; Carl Zeiss) and Axiovision AC software (version 4.4; Carl Zeiss).
Immunofluorescence
Cells at 80% confluence were washed in PBS, fixed in ice-cold 4% para-
formaldehyde for 10 min, and blocked in 3% donkey serum PBS with or 
without 0.1% Triton X-100 at 4°C for 1 h. The cells were incubated with 
primary antibodies in 1 mg/ml BSA in PBS with or without 0.1% Triton 
X-100 at 4°C overnight followed by washing and detection with Alexa 
Fluor dye–conjugated secondary antibodies (Invitrogen). Images were cap-
tured on an upright wide-field fluorescence microscope (BX-61 [Olympus] 
or Axioskop Plus) using SlideBook (Intelligent Imaging Innovations, Inc.) 
or Axiovision version 4.6 software, and acquired data were normalized 
using standard parameters in Photoshop (CS3; Adobe). Raw tiff data were 
overlaid into separate color channels, composited, and cropped using 
Photoshop. Identical settings were used for fluorescence excitation, image 
capture, and level adjustment for all comparative analyses. Figures were 
created in Illustrator (CS3; Adobe).949 Collagen disruption in Mia3
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paragraph. Images were acquired using a color camera (AxioCam HRc; 
Carl Zeiss) controlled via AxioVision v4.8.1 software.  adjustments and 
overlays were performed in Photoshop using standard techniques.
All nonfluorescent images were collected on a microscope (SteREO 
Discovery.V12;  Carl  Zeiss)  with  M
2  Bio  attachment  equipped  with  an 
Achromat S FWD 69-mm lens (Carl Zeiss) at an ambient temperature. 
Skeletons were cleared and mounted in 80% glycerol, whereas in situ 
hybridizations were permanently mounted using Poly-Mount (Polysciences, 
Inc.). Images were acquired on an color camera (AxioCam HRc) controlled 
with AxioVision AC software v4.4.0.0.  adjustments and composites were 
performed in Photoshop using standard techniques. Low resolution bone 
in situ hybridization images were composited from multiple tiff files with a 
maximal 5–10-cell diameter overlap using Interactive Photomerge.
Online supplemental material
Fig. S1 shows characterization of the Mia3 locus, transcripts, and targeting 
design. Fig. S2 shows validation of anti-Mia3 polyclonal antibodies. Fig. S3 
demonstrates additional expression and metabolism analyses in Mia3-null 
primary cell cultures. Fig. S4 provides a description of normal deposition of 
fibronectin and aggrecan in Mia3 knockout tissues. Fig. S5 shows a descrip-
tion of significant UPR/ER stress gene up-regulation in Mia3
/ chondrocytes 
and fibroblasts at 16.5 dpc. Table S1 summarizes antibody reagent data. 
Table S2 shows in situ probe information. Table S3 shows TaqMan quantita-
tive PCR primer/probes used in this study. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.201007162/DC1.
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